Charlene Lancaster, PhD | Jun 27, 2024 | 4 min read
Generative artificial intelligence allowed researchers to design new, synthesizable antibiotics against a dangerous and often drug-resistant human pathogen.
Scientists built a microfluidic lab-on-a-chip device that accelerates compound screens and phenotype analyses in C. elegans models of reproductive aging.
In this webinar, Elizabeth Proctor will discuss the latest organoid models that scientists use to advance human disease research, with a focus on promoting drug discovery and precision medicine.
As a trailblazer in rare disease research and treatment, Wendy Chung captures the big picture of rare disease genetics with the help of next generation sequencing.
A step-by-step cell culture process may improve the quantity and quality of cell replacement therapies.
ADVERTISEMENT
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.